_id
69130816ccc777a4e85d7b3f
Ticker
JSPRW
Name
Jasper Therapeutics Inc
Exchange
NASDAQ
Address
2200 Bridge Pkwy, Redwood City, CA, United States, 94065
Country
USA
Sector
Industry
Currency
USD
Website
https://jaspertx.com
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.
Last Close
0.08
Volume
62964
Current Price
0.0799
Change
0.0281
Last Updated
2026-01-04T15:49:38.200Z
Image
data:image/webp;base64,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
Ipo Date
2020-01-10T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
19166000
Operating Income
-19166000
Interest Expense
-
Pretax Income
-18736000
Net Income
-18736000
Eps
-1.1262468904381062
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-18507000
Operating Margin
-
Total Other Income Expense Net
430000
Cash
50899000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
54564000
Property Plant Equipment
2338000
Total Assets
57469000
Payables
9166000
Short Term Debt
1703000
Long Term Debt
-
Total Liabilities
45898000
Equity
11571000
Bs_currency_symbol
USD
Depreciation
229000
Change In Working Capital
-187000
Cash From Operations
-16999000
Capital Expenditures
0
Cash From Investing
76000
Cash From Financing
28388000
Net Change In Cash
11389000
Cf_currency_symbol
USD
PE
-
PB
0.11487331618701926
ROE
-161.9220464955492
ROA
-32.60192451582593
FCF
-16999000
Fcf Percent
-
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
19166000
Quarters > 0 > income Statement > operating Income
-19166000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-18736000
Quarters > 0 > income Statement > net Income
-18736000
Quarters > 0 > income Statement > eps
-1.1262468904381062
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16635784
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-18507000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
430000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
50899000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
54564000
Quarters > 0 > balance Sheet > property Plant Equipment
2338000
Quarters > 0 > balance Sheet > total Assets
57469000
Quarters > 0 > balance Sheet > payables
9166000
Quarters > 0 > balance Sheet > short Term Debt
1703000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
45898000
Quarters > 0 > balance Sheet > equity
11571000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-18736000
Quarters > 0 > cash Flow > depreciation
229000
Quarters > 0 > cash Flow > change In Working Capital
-187000
Quarters > 0 > cash Flow > cash From Operations
-16999000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
76000
Quarters > 0 > cash Flow > cash From Financing
28388000
Quarters > 0 > cash Flow > net Change In Cash
11389000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.1262468904381062
Quarters > 0 > ratios > PB
0.11487331618701926
Quarters > 0 > ratios > ROE
-161.9220464955492
Quarters > 0 > ratios > ROA
-32.60192451582593
Quarters > 0 > ratios > FCF
-16999000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
258000
Quarters > 1 > income Statement > gross Profit
-258000
Quarters > 1 > income Statement > operating Expenses
27076000
Quarters > 1 > income Statement > operating Income
-27076000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-26723000
Quarters > 1 > income Statement > net Income
-26723000
Quarters > 1 > income Statement > eps
-1.74273289577736
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15333962
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-26818000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
353000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
39510000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
42966000
Quarters > 1 > balance Sheet > property Plant Equipment
2891000
Quarters > 1 > balance Sheet > total Assets
46466000
Quarters > 1 > balance Sheet > payables
8034000
Quarters > 1 > balance Sheet > short Term Debt
1954000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
22965000
Quarters > 1 > balance Sheet > equity
23501000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-26723000
Quarters > 1 > cash Flow > depreciation
258000
Quarters > 1 > cash Flow > change In Working Capital
8878000
Quarters > 1 > cash Flow > cash From Operations
-15453000
Quarters > 1 > cash Flow > capital Expenditures
7000
Quarters > 1 > cash Flow > cash From Investing
1000
Quarters > 1 > cash Flow > cash From Financing
6163000
Quarters > 1 > cash Flow > net Change In Cash
-9289000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.74273289577736
Quarters > 1 > ratios > PB
0.0521332523637292
Quarters > 1 > ratios > ROE
-113.71005489128123
Quarters > 1 > ratios > ROA
-57.51086816166659
Quarters > 1 > ratios > FCF
-15460000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
279000
Quarters > 2 > income Statement > gross Profit
-279000
Quarters > 2 > income Statement > operating Expenses
21802000
Quarters > 2 > income Statement > operating Income
-21802000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-21241000
Quarters > 2 > income Statement > net Income
-21241000
Quarters > 2 > income Statement > eps
-1.4139813270055988
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15022122
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-21523000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
561000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
48799000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
53174000
Quarters > 2 > balance Sheet > property Plant Equipment
3474000
Quarters > 2 > balance Sheet > total Assets
57597000
Quarters > 2 > balance Sheet > payables
2995000
Quarters > 2 > balance Sheet > short Term Debt
1835000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
15353000
Quarters > 2 > balance Sheet > equity
42244000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-21241000
Quarters > 2 > cash Flow > depreciation
279000
Quarters > 2 > cash Flow > change In Working Capital
-3884000
Quarters > 2 > cash Flow > cash From Operations
-22842000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
4000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-22838000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.4139813270055988
Quarters > 2 > ratios > PB
0.0284127343007291
Quarters > 2 > ratios > ROE
-50.2816968090143
Quarters > 2 > ratios > ROA
-36.87865687448999
Quarters > 2 > ratios > FCF
-22842000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1174000
Quarters > 3 > income Statement > cost Of Revenue
587000
Quarters > 3 > income Statement > gross Profit
587000
Quarters > 3 > income Statement > operating Expenses
25285000
Quarters > 3 > income Statement > operating Income
-25285000
Quarters > 3 > income Statement > interest Expense
5058000
Quarters > 3 > income Statement > pretax Income
-24321000
Quarters > 3 > income Statement > net Income
-24321000
Quarters > 3 > income Statement > eps
-1.6204846422417525
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
15008473
Quarters > 3 > income Statement > income Tax Expense
54276
Quarters > 3 > income Statement > EBITDA
-25040000
Quarters > 3 > income Statement > operating Margin
-2153.7478705281087
Quarters > 3 > income Statement > total Other Income Expense Net
964000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
71637000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
75811000
Quarters > 3 > balance Sheet > property Plant Equipment
2851000
Quarters > 3 > balance Sheet > total Assets
79899000
Quarters > 3 > balance Sheet > payables
4027000
Quarters > 3 > balance Sheet > short Term Debt
1089000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
18225000
Quarters > 3 > balance Sheet > equity
61674000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-24321000
Quarters > 3 > cash Flow > depreciation
245000
Quarters > 3 > cash Flow > change In Working Capital
831000
Quarters > 3 > cash Flow > cash From Operations
-21134000
Quarters > 3 > cash Flow > capital Expenditures
96000
Quarters > 3 > cash Flow > cash From Investing
-76000
Quarters > 3 > cash Flow > cash From Financing
345000
Quarters > 3 > cash Flow > net Change In Cash
-20865000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.6204846422417525
Quarters > 3 > ratios > PB
0.019443801159321594
Quarters > 3 > ratios > ROE
-39.434769919252844
Quarters > 3 > ratios > ROA
-30.439680096121354
Quarters > 3 > ratios > FCF
-21230000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-18.083475298126064
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1373000
Annuals > 0 > income Statement > gross Profit
-1373000
Annuals > 0 > income Statement > operating Expenses
76239000
Annuals > 0 > income Statement > operating Income
-76239000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-71269000
Annuals > 0 > income Statement > net Income
-71269000
Annuals > 0 > income Statement > eps
-4.886502245134856
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
14584870
Annuals > 0 > income Statement > income Tax Expense
-1492000
Annuals > 0 > income Statement > EBITDA
-74866000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4970000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
71637000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
75811000
Annuals > 0 > balance Sheet > property Plant Equipment
2851000
Annuals > 0 > balance Sheet > total Assets
79899000
Annuals > 0 > balance Sheet > payables
4027000
Annuals > 0 > balance Sheet > short Term Debt
1089000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
18225000
Annuals > 0 > balance Sheet > equity
61674000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-71269000
Annuals > 0 > cash Flow > depreciation
1373000
Annuals > 0 > cash Flow > change In Working Capital
173000
Annuals > 0 > cash Flow > cash From Operations
-62602000
Annuals > 0 > cash Flow > capital Expenditures
552000
Annuals > 0 > cash Flow > cash From Investing
-532000
Annuals > 0 > cash Flow > cash From Financing
47884000
Annuals > 0 > cash Flow > net Change In Cash
-15250000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.886502245134856
Annuals > 0 > ratios > PB
0.01612815990530856
Annuals > 0 > ratios > ROE
-115.55760936537276
Annuals > 0 > ratios > ROA
-89.19886356525113
Annuals > 0 > ratios > FCF
-63154000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1108000
Annuals > 1 > income Statement > gross Profit
-1108000
Annuals > 1 > income Statement > operating Expenses
68861000
Annuals > 1 > income Statement > operating Income
-68861000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-64465000
Annuals > 1 > income Statement > net Income
-64465000
Annuals > 1 > income Statement > eps
-6.175379829206419
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10439034
Annuals > 1 > income Statement > income Tax Expense
-1628000
Annuals > 1 > income Statement > EBITDA
-67753000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
4396000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
86887000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
250000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
88938000
Annuals > 1 > balance Sheet > property Plant Equipment
4194000
Annuals > 1 > balance Sheet > total Assets
94892000
Annuals > 1 > balance Sheet > payables
4149000
Annuals > 1 > balance Sheet > short Term Debt
972000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
16452000
Annuals > 1 > balance Sheet > equity
78440000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-64465000
Annuals > 1 > cash Flow > depreciation
1108000
Annuals > 1 > cash Flow > change In Working Capital
5103000
Annuals > 1 > cash Flow > cash From Operations
-52067000
Annuals > 1 > cash Flow > capital Expenditures
267000
Annuals > 1 > cash Flow > cash From Investing
-267000
Annuals > 1 > cash Flow > cash From Financing
100971000
Annuals > 1 > cash Flow > net Change In Cash
48637000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-6.175379829206419
Annuals > 1 > ratios > PB
0.009076263625701173
Annuals > 1 > ratios > ROE
-82.1838347781744
Annuals > 1 > ratios > ROA
-67.9351262487881
Annuals > 1 > ratios > FCF
-52334000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1310000
Annuals > 2 > income Statement > gross Profit
-1310000
Annuals > 2 > income Statement > operating Expenses
51196000
Annuals > 2 > income Statement > operating Income
-51196000
Annuals > 2 > income Statement > interest Expense
13511000
Annuals > 2 > income Statement > pretax Income
-37685000
Annuals > 2 > income Statement > net Income
-37685000
Annuals > 2 > income Statement > eps
-10.329921549063359
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3648140
Annuals > 2 > income Statement > income Tax Expense
-13511000
Annuals > 2 > income Statement > EBITDA
-50221000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
13511000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
38250000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1159000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
41731000
Annuals > 2 > balance Sheet > property Plant Equipment
5454000
Annuals > 2 > balance Sheet > total Assets
48361000
Annuals > 2 > balance Sheet > payables
1768000
Annuals > 2 > balance Sheet > short Term Debt
865000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
12372000
Annuals > 2 > balance Sheet > equity
35989000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-37685000
Annuals > 2 > cash Flow > depreciation
1310000
Annuals > 2 > cash Flow > change In Working Capital
-649000
Annuals > 2 > cash Flow > cash From Operations
-45858000
Annuals > 2 > cash Flow > capital Expenditures
576000
Annuals > 2 > cash Flow > cash From Investing
-576000
Annuals > 2 > cash Flow > cash From Financing
55000
Annuals > 2 > cash Flow > net Change In Cash
-46451000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-10.329921549063359
Annuals > 2 > ratios > PB
0.0069133109561254815
Annuals > 2 > ratios > ROE
-104.71255105726749
Annuals > 2 > ratios > ROA
-77.9243605384504
Annuals > 2 > ratios > FCF
-46434000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
566000
Annuals > 3 > income Statement > gross Profit
-566000
Annuals > 3 > income Statement > operating Expenses
36833000
Annuals > 3 > income Statement > operating Income
-36833000
Annuals > 3 > income Statement > interest Expense
6653000
Annuals > 3 > income Statement > pretax Income
-30637000
Annuals > 3 > income Statement > net Income
-30637000
Annuals > 3 > income Statement > eps
-26.88930334613275
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1139375
Annuals > 3 > income Statement > income Tax Expense
-1095000
Annuals > 3 > income Statement > EBITDA
-36456000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
6196000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
84701000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
698000
Annuals > 3 > balance Sheet > inventories
-548000
Annuals > 3 > balance Sheet > total Current Assets
87831000
Annuals > 3 > balance Sheet > property Plant Equipment
4833000
Annuals > 3 > balance Sheet > total Assets
93654000
Annuals > 3 > balance Sheet > payables
3919000
Annuals > 3 > balance Sheet > short Term Debt
505000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
24136000
Annuals > 3 > balance Sheet > equity
69518000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-30637000
Annuals > 3 > cash Flow > depreciation
377000
Annuals > 3 > cash Flow > change In Working Capital
1621000
Annuals > 3 > cash Flow > cash From Operations
-33678000
Annuals > 3 > cash Flow > capital Expenditures
2428000
Annuals > 3 > cash Flow > cash From Investing
-2428000
Annuals > 3 > cash Flow > cash From Financing
100969000
Annuals > 3 > cash Flow > net Change In Cash
64863000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-26.88930334613275
Annuals > 3 > ratios > PB
0.0011177734543571449
Annuals > 3 > ratios > ROE
-44.0706004200351
Annuals > 3 > ratios > ROA
-32.71296474256305
Annuals > 3 > ratios > FCF
-36106000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.1262468904381062
Valuation > metrics > PB
0.11487331618701926
Valuation > final Score
70
Valuation > verdict
88.5% Undervalued
Profitability > metrics > ROE
-161.9220464955492
Profitability > metrics > ROA
-34.33765852943333
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.9666407397804857
Risk > metrics > Interest Coverage
-83.6943231441048
Risk > final Score
-329
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.020149047750483
Liquidity > metrics > Quick Ratio
5.020149047750483
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1092
Prev Risks > 1
-249
Prev Risks > 2
40
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:04:45.364Z
Earnings History > 0 > period
2021-06-30
Earnings History > 0 > report Date
2021-09-30
Earnings History > 0 > date
2021-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.687
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.687
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.8281
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.8281
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.9931
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.9931
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-09-30
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-6.1411
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-6.1411
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-03-31
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.6059
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-1.6059
Earnings History > 4 > surprise Percent
-
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMoving Averages: Does NRSNW meet Warren Buffetts criteria - July 2025 Drop Watch & Risk Managed Investment Signals baoquankhu1.vn
Read more →Is JSPRW benefiting from innovation trends - Price Support Zones & Affordable Growth Trading bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Jasper Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-06-30
EPS Actual
-0.687
EPS Estimate
0
EPS Difference
-0.687
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.